Group One Trading’s Audentes Therapeutics, Inc BOLD Stock Holding History

Group One Trading’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-21,800	Closed	-$1.3M	–	6121
2019 Q4	$1.3M	Buy	+21,800	New	+$818K	0.01%	1656
2019 Q2	–	Sell	-3,700	Closed	-$144K	–	5678
2019 Q1	$144K	Buy	3,700 +3,300	+825%	+$94.6K	﹤0.01%	2933
2018 Q4	$9K	Buy	400 +300	+300%	+$7.74K	﹤0.01%	4326
2018 Q3	$4K	Sell	100 -400	-80%	-$14.9K	﹤0.01%	4934
2018 Q2	$19K	Buy	500 +300	+150%	+$11.1K	﹤0.01%	4392
2018 Q1	$6K	Buy	+200	New	+$6.77K	﹤0.01%	4490

Group One Trading's BOLD Position: Q4 2019 in Review

Group One Trading sold out of Audentes Therapeutics, Inc (BOLD) in Q4 2019, closing a stake of 6,413 shares — an estimated $241K sold.

Group One Trading first reported a position in BOLD in Q3 2018 and held it in 4 quarters. The position peaked at $180K in Q3 2019. 188 funds tracked by Wall St. Rank hold BOLD as of Q4 2019.

Group One Trading reported no remaining Audentes Therapeutics, Inc position as of Q4 2019 after selling out during the quarter.
Group One Trading sold 6,413 Audentes Therapeutics, Inc shares in Q4 2019, an estimated $241K.
Group One Trading first reported a position in Audentes Therapeutics, Inc in Q3 2018 and held it in 4 quarters.
Group One Trading's Audentes Therapeutics, Inc position peaked at $180K in Q3 2019.
188 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q4 2019.

Based on Group One Trading's 13F filing for Q4 2019, filed 10 Feb 2020.